Skip to main content
Screener/Healthcare/Biotechnology

NRIX — Nurix Therapeutics, Inc.

NASDAQ
$26.66-0.51 (-1.88%)
Mid CapUnder $50HealthcareHigh Beta
$11.50
$28.23
$25.97
$26.91
EPS (TTM)$-3.16
P/E Ratio-6.37
Dividend Yield—
Market Cap$2.77B
Volume1.44M
Prev Close$27.12
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$6.3M-$87.2M$-0.79-1245.8%-1394.3%
Q4 '25$13.6M-$78.2M$-0.8265.9%-576.1%
Q3 '25$7.9M-$86.4M$-1.0336.7%-1094.8%
Q2 '25$44.1M-$43.5M$-0.52-77.3%-98.7%
Q1 '25$18.5M-$56.4M$-0.67-277.5%-305.4%
Q4 '24$13.3M-$58.5M$-0.75-406.1%-440.7%
Q3 '24$12.6M-$49.0M$-0.67-340.7%-388.9%
Q2 '24$12.1M-$44.5M$-0.71-304.6%-368.4%
Get Your Daily Market Recap